Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 29018 entries
Sorted by: Best Match Show Resources per page
Waist circumference and insulin resistance: a community based cross sectional study on reproductive aged Iranian women.

Diabetology & metabolic syndrome

Zadeh-Vakili A, Tehrani FR, Hosseinpanah F.
PMID: 21831271
Diabetol Metab Syndr. 2011 Aug 10;3:18. doi: 10.1186/1758-5996-3-18.

BACKGROUND: Although the positive relationship between insulin resistance (IR) and central obesity is well known, the direct relationship between waist circumference and IR is not clear yet and there is no consensus regarding the cut off value for waist...

Cite
Zadeh-Vakili A, Tehrani FR, Hosseinpanah F. Waist circumference and insulin resistance: a community based cross sectional study on reproductive aged Iranian women. Diabetol Metab Syndr. 2011;3:18doi: 10.1186/1758-5996-3-18.
Zadeh-Vakili, A., Tehrani, F. R., & Hosseinpanah, F. (2011). Waist circumference and insulin resistance: a community based cross sectional study on reproductive aged Iranian women. Diabetology & metabolic syndrome, 318. https://doi.org/10.1186/1758-5996-3-18
Zadeh-Vakili, Azita, et al. "Waist circumference and insulin resistance: a community based cross sectional study on reproductive aged Iranian women." Diabetology & metabolic syndrome vol. 3 (2011): 18. doi: https://doi.org/10.1186/1758-5996-3-18
Zadeh-Vakili A, Tehrani FR, Hosseinpanah F. Waist circumference and insulin resistance: a community based cross sectional study on reproductive aged Iranian women. Diabetol Metab Syndr. 2011 Aug 10;3:18. doi: 10.1186/1758-5996-3-18. PMID: 21831271; PMCID: PMC3170572.
Copy Download .nbib Format: NLM
Clinical relevance of the reappraisal of negative hormone receptor expression in breast cancer.

SpringerPlus

Pinto AE, Areia F, Pereira T, Cardoso P, Aparício M, Silva GL, Ferreira MC, André S.
PMID: 24010033
Springerplus. 2013 Aug 09;2:375. doi: 10.1186/2193-1801-2-375. eCollection 2013.

BACKGROUND: Accurate assessment of estrogen (ER) and progesterone (PR) receptors is critical in predicting the response to endocrine therapies in breast cancer.MATERIAL AND METHODS: From a series of 360 patients with breast invasive carcinoma assessed for hormone receptors by...

Cite
Pinto AE, Areia F, Pereira T, et al. Clinical relevance of the reappraisal of negative hormone receptor expression in breast cancer. Springerplus. 2013;2:375doi: 10.1186/2193-1801-2-375.
Pinto, A. E., Areia, F., Pereira, T., Cardoso, P., Aparício, M., Silva, G. L., Ferreira, M. C., & André, S. (2013). Clinical relevance of the reappraisal of negative hormone receptor expression in breast cancer. SpringerPlus, 2375. https://doi.org/10.1186/2193-1801-2-375
Pinto, António E, et al. "Clinical relevance of the reappraisal of negative hormone receptor expression in breast cancer." SpringerPlus vol. 2 (2013): 375. doi: https://doi.org/10.1186/2193-1801-2-375
Pinto AE, Areia F, Pereira T, Cardoso P, Aparício M, Silva GL, Ferreira MC, André S. Clinical relevance of the reappraisal of negative hormone receptor expression in breast cancer. Springerplus. 2013 Aug 09;2:375. doi: 10.1186/2193-1801-2-375. eCollection 2013. PMID: 24010033; PMCID: PMC3755814.
Copy Download .nbib Format: NLM
Medical management of pituitary-dependent hyperadrenocorticism: mitotane versus trilostane.

Topics in companion animal medicine

Reine NJ.
PMID: 22958794
Top Companion Anim Med. 2012 Feb;27(1):25-30. doi: 10.1053/j.tcam.2012.06.002.

Pituitary-dependent hyperadrenocorticism is a common endocrine disorder in dogs in the United States. Once a diagnosis is established, a decision must be made whether or not to pursue treatment, and if so, which medication to use. Historically, mitotane (Lysodren,...

Cite
Reine NJ. Medical management of pituitary-dependent hyperadrenocorticism: mitotane versus trilostane. Top Companion Anim Med. 2012;27(1):25-30doi: 10.1053/j.tcam.2012.06.002.
Reine, N. J. (2012). Medical management of pituitary-dependent hyperadrenocorticism: mitotane versus trilostane. Topics in companion animal medicine, 27(1), 25-30. https://doi.org/10.1053/j.tcam.2012.06.002
Reine, Nyssa J. "Medical management of pituitary-dependent hyperadrenocorticism: mitotane versus trilostane." Topics in companion animal medicine vol. 27,1 (2012): 25-30. doi: https://doi.org/10.1053/j.tcam.2012.06.002
Reine NJ. Medical management of pituitary-dependent hyperadrenocorticism: mitotane versus trilostane. Top Companion Anim Med. 2012 Feb;27(1):25-30. doi: 10.1053/j.tcam.2012.06.002. PMID: 22958794.
Copy Download .nbib Format: NLM
Association of blood manganese level with diabetes and renal dysfunction: a cross-sectional study of the Korean general population.

BMC endocrine disorders

Koh ES, Kim SJ, Yoon HE, Chung JH, Chung S, Park CW, Chang YS, Shin SJ.
PMID: 24606630
BMC Endocr Disord. 2014 Mar 08;14:24. doi: 10.1186/1472-6823-14-24.

BACKGROUND: The purpose of this study was to evaluate the association between blood manganese levels and the prevalence of chronic diseases in the Korean population.METHODS: This was a cross-sectional study based on the Korean National Health and Nutrition Examination...

Cite
Koh ES, Kim SJ, Yoon HE, et al. Association of blood manganese level with diabetes and renal dysfunction: a cross-sectional study of the Korean general population. BMC Endocr Disord. 2014;14:24doi: 10.1186/1472-6823-14-24.
Koh, E. S., Kim, S. J., Yoon, H. E., Chung, J. H., Chung, S., Park, C. W., Chang, Y. S., & Shin, S. J. (2014). Association of blood manganese level with diabetes and renal dysfunction: a cross-sectional study of the Korean general population. BMC endocrine disorders, 1424. https://doi.org/10.1186/1472-6823-14-24
Koh, Eun Sil, et al. "Association of blood manganese level with diabetes and renal dysfunction: a cross-sectional study of the Korean general population." BMC endocrine disorders vol. 14 (2014): 24. doi: https://doi.org/10.1186/1472-6823-14-24
Koh ES, Kim SJ, Yoon HE, Chung JH, Chung S, Park CW, Chang YS, Shin SJ. Association of blood manganese level with diabetes and renal dysfunction: a cross-sectional study of the Korean general population. BMC Endocr Disord. 2014 Mar 08;14:24. doi: 10.1186/1472-6823-14-24. PMID: 24606630; PMCID: PMC3973834.
Copy Download .nbib Format: NLM
Unilateral adrenal hyperplasia is a usual cause of primary hyperaldosteronism. Results from a Swedish screening study.

BMC endocrine disorders

Sigurjonsdottir HA, Gronowitz M, Andersson O, Eggertsen R, Herlitz H, Sakinis A, Wangberg B, Johannsson G.
PMID: 22958674
BMC Endocr Disord. 2012 Sep 08;12:17. doi: 10.1186/1472-6823-12-17.

BACKGROUND: The existence of unilateral adrenal hyperplasia (AH) has been considered a rare cause of primary hyperaldosteronism (PA).METHODS: In a prospective study we screened for PA in a non-selected (NSP) and selected hypertensive population (SP), to define the cause...

Cite
Sigurjonsdottir HA, Gronowitz M, Andersson O, et al. Unilateral adrenal hyperplasia is a usual cause of primary hyperaldosteronism. Results from a Swedish screening study. BMC Endocr Disord. 2012;12:17doi: 10.1186/1472-6823-12-17.
Sigurjonsdottir, H. A., Gronowitz, M., Andersson, O., Eggertsen, R., Herlitz, H., Sakinis, A., Wangberg, B., & Johannsson, G. (2012). Unilateral adrenal hyperplasia is a usual cause of primary hyperaldosteronism. Results from a Swedish screening study. BMC endocrine disorders, 1217. https://doi.org/10.1186/1472-6823-12-17
Sigurjonsdottir, Helga Agusta, et al. "Unilateral adrenal hyperplasia is a usual cause of primary hyperaldosteronism. Results from a Swedish screening study." BMC endocrine disorders vol. 12 (2012): 17. doi: https://doi.org/10.1186/1472-6823-12-17
Sigurjonsdottir HA, Gronowitz M, Andersson O, Eggertsen R, Herlitz H, Sakinis A, Wangberg B, Johannsson G. Unilateral adrenal hyperplasia is a usual cause of primary hyperaldosteronism. Results from a Swedish screening study. BMC Endocr Disord. 2012 Sep 08;12:17. doi: 10.1186/1472-6823-12-17. PMID: 22958674; PMCID: PMC3515501.
Copy Download .nbib Format: NLM
Mandibular reconstruction using an axially vascularized tissue-engineered construct.

Annals of surgical innovation and research

Eweida AM, Nabawi AS, Marei MK, Khalil MR, Elhammady HA.
PMID: 21418603
Ann Surg Innov Res. 2011 Mar 20;5:2. doi: 10.1186/1750-1164-5-2.

BACKGROUND: Current reconstructive techniques for continuity defects of the mandible include the use of free flaps, bone grafts, and alloplastic materials. New methods of regenerative medicine designed to restore tissues depend mainly on the so-called extrinsic neovascularization, where the...

Cite
Eweida AM, Nabawi AS, Marei MK, et al. Mandibular reconstruction using an axially vascularized tissue-engineered construct. Ann Surg Innov Res. 2011;5:2doi: 10.1186/1750-1164-5-2.
Eweida, A. M., Nabawi, A. S., Marei, M. K., Khalil, M. R., & Elhammady, H. A. (2011). Mandibular reconstruction using an axially vascularized tissue-engineered construct. Annals of surgical innovation and research, 52. https://doi.org/10.1186/1750-1164-5-2
Eweida, Ahmad M, et al. "Mandibular reconstruction using an axially vascularized tissue-engineered construct." Annals of surgical innovation and research vol. 5 (2011): 2. doi: https://doi.org/10.1186/1750-1164-5-2
Eweida AM, Nabawi AS, Marei MK, Khalil MR, Elhammady HA. Mandibular reconstruction using an axially vascularized tissue-engineered construct. Ann Surg Innov Res. 2011 Mar 20;5:2. doi: 10.1186/1750-1164-5-2. PMID: 21418603; PMCID: PMC3069948.
Copy Download .nbib Format: NLM
The organochlorine pesticides residue levels in karun river water.

Jundishapur journal of natural pharmaceutical products

Behfar A, Nazari Z, Rabiee MH, Raeesi G, Oveisi MR, Sadeghi N, Jannat B.
PMID: 24624185
Jundishapur J Nat Pharm Prod. 2013;8(1):41-6. Epub 2013 Feb 13.

BACKGROUND: The organochlorine pesticides (OCPs) are among the most commonly used in water streams around the world. Most of these contaminants are highly hydrophobic and persist in sediments of rivers and lakes. Studies have suggested that OCPs may affect...

Cite
Behfar A, Nazari Z, Rabiee MH, et al. The organochlorine pesticides residue levels in karun river water. Jundishapur J Nat Pharm Prod. 2013;8(1):41-6
Behfar, A., Nazari, Z., Rabiee, M. H., Raeesi, G., Oveisi, M. R., Sadeghi, N., & Jannat, B. (2013). The organochlorine pesticides residue levels in karun river water. Jundishapur journal of natural pharmaceutical products, 8(1), 41-6.
Behfar, Abdolazim, et al. "The organochlorine pesticides residue levels in karun river water." Jundishapur journal of natural pharmaceutical products vol. 8,1 (2013): 41-6.
Behfar A, Nazari Z, Rabiee MH, Raeesi G, Oveisi MR, Sadeghi N, Jannat B. The organochlorine pesticides residue levels in karun river water. Jundishapur J Nat Pharm Prod. 2013;8(1):41-6. Epub 2013 Feb 13. PMID: 24624185; PMCID: PMC3941877.
Copy Download .nbib Format: NLM
An endocrine hypothesis for the genesis of atrial fibrillation: the hypothalamic-pituitary-adrenal axis response to stress and glycogen accumulation in atrial tissues.

North American journal of medical sciences

Embi AA, Scherlag BJ.
PMID: 25535608
N Am J Med Sci. 2014 Nov;6(11):586-90. doi: 10.4103/1947-2714.145478.

BACKGROUND: The underlying role of intracellular glycogen in atrial fibrillation is unknown. Experimental models developed in the goat have shown an increase of intracellular glycogen concentration in atrial myocytes resulting from prolonged pacing induced atrial fibrillation (AF). These observed...

Cite
Embi AA, Scherlag BJ. An endocrine hypothesis for the genesis of atrial fibrillation: the hypothalamic-pituitary-adrenal axis response to stress and glycogen accumulation in atrial tissues. N Am J Med Sci. 2014;6(11):586-90doi: 10.4103/1947-2714.145478.
Embi, A. A., & Scherlag, B. J. (2014). An endocrine hypothesis for the genesis of atrial fibrillation: the hypothalamic-pituitary-adrenal axis response to stress and glycogen accumulation in atrial tissues. North American journal of medical sciences, 6(11), 586-90. https://doi.org/10.4103/1947-2714.145478
Embi, Abraham A, and Scherlag, Benjamin J. "An endocrine hypothesis for the genesis of atrial fibrillation: the hypothalamic-pituitary-adrenal axis response to stress and glycogen accumulation in atrial tissues." North American journal of medical sciences vol. 6,11 (2014): 586-90. doi: https://doi.org/10.4103/1947-2714.145478
Embi AA, Scherlag BJ. An endocrine hypothesis for the genesis of atrial fibrillation: the hypothalamic-pituitary-adrenal axis response to stress and glycogen accumulation in atrial tissues. N Am J Med Sci. 2014 Nov;6(11):586-90. doi: 10.4103/1947-2714.145478. PMID: 25535608; PMCID: PMC4264295.
Copy Download .nbib Format: NLM
Use of mTOR inhibitors in the treatment of breast cancer: an evaluation of factors that influence patient outcomes.

Breast cancer (Dove Medical Press)

Jerusalem G, Rorive A, Collignon J.
PMID: 24833916
Breast Cancer (Dove Med Press). 2014 Apr 17;6:43-57. doi: 10.2147/BCTT.S38679. eCollection 2014.

Many systemic treatment options are available for advanced breast cancer, including endocrine therapy, chemotherapy, anti-human epidermal growth factor receptor 2 (HER2) therapy, and other targeted agents. Recently, everolimus, a mammalian target of rapamycin (mTOR) inhibitor, combined with exemestane, an...

Cite
Jerusalem G, Rorive A, Collignon J. Use of mTOR inhibitors in the treatment of breast cancer: an evaluation of factors that influence patient outcomes. Breast Cancer (Dove Med Press). 2014;6:43-57doi: 10.2147/BCTT.S38679.
Jerusalem, G., Rorive, A., & Collignon, J. (2014). Use of mTOR inhibitors in the treatment of breast cancer: an evaluation of factors that influence patient outcomes. Breast cancer (Dove Medical Press), 643-57. https://doi.org/10.2147/BCTT.S38679
Jerusalem, Guy, et al. "Use of mTOR inhibitors in the treatment of breast cancer: an evaluation of factors that influence patient outcomes." Breast cancer (Dove Medical Press) vol. 6 (2014): 43-57. doi: https://doi.org/10.2147/BCTT.S38679
Jerusalem G, Rorive A, Collignon J. Use of mTOR inhibitors in the treatment of breast cancer: an evaluation of factors that influence patient outcomes. Breast Cancer (Dove Med Press). 2014 Apr 17;6:43-57. doi: 10.2147/BCTT.S38679. eCollection 2014. PMID: 24833916; PMCID: PMC4000187.
Copy Download .nbib Format: NLM
Targeted Therapies Overcoming Endocrine Resistance in Hormone Receptor-Positive Breast Cancer.

Breast care (Basel, Switzerland)

Almstedt K, Schmidt M.
PMID: 26557821
Breast Care (Basel). 2015 Jul;10(3):168-72. doi: 10.1159/000405017. Epub 2015 May 13.

Breast cancer is a heterogeneous disease with different molecular subtypes. Most tumours are hormone receptor positive (luminal subtype) with potential endocrine responsiveness. Endocrine therapy is commonly used in these patients. Disease progression caused by endocrine resistance represents a significant...

Cite
Almstedt K, Schmidt M. Targeted Therapies Overcoming Endocrine Resistance in Hormone Receptor-Positive Breast Cancer. Breast Care (Basel). 2015;10(3):168-72doi: 10.1159/000405017.
Almstedt, K., & Schmidt, M. (2015). Targeted Therapies Overcoming Endocrine Resistance in Hormone Receptor-Positive Breast Cancer. Breast care (Basel, Switzerland), 10(3), 168-72. https://doi.org/10.1159/000405017
Almstedt, Katrin, and Schmidt, Marcus. "Targeted Therapies Overcoming Endocrine Resistance in Hormone Receptor-Positive Breast Cancer." Breast care (Basel, Switzerland) vol. 10,3 (2015): 168-72. doi: https://doi.org/10.1159/000405017
Almstedt K, Schmidt M. Targeted Therapies Overcoming Endocrine Resistance in Hormone Receptor-Positive Breast Cancer. Breast Care (Basel). 2015 Jul;10(3):168-72. doi: 10.1159/000405017. Epub 2015 May 13. PMID: 26557821; PMCID: PMC4569254.
Copy Download .nbib Format: NLM
Under-recognition of the benefits of parathyroidectomy leads to underdiagnosis of the disease.

Surgery

Sippel RS.
PMID: 24238046
Surgery. 2013 Dec;154(6):1230-1. doi: 10.1016/j.surg.2013.05.042.

No abstract available.

Cite
Sippel RS. Under-recognition of the benefits of parathyroidectomy leads to underdiagnosis of the disease. Surgery. 2013;154(6):1230-1doi: 10.1016/j.surg.2013.05.042.
Sippel, R. S. (2013). Under-recognition of the benefits of parathyroidectomy leads to underdiagnosis of the disease. Surgery, 154(6), 1230-1. https://doi.org/10.1016/j.surg.2013.05.042
Sippel, Rebecca S. "Under-recognition of the benefits of parathyroidectomy leads to underdiagnosis of the disease." Surgery vol. 154,6 (2013): 1230-1. doi: https://doi.org/10.1016/j.surg.2013.05.042
Sippel RS. Under-recognition of the benefits of parathyroidectomy leads to underdiagnosis of the disease. Surgery. 2013 Dec;154(6):1230-1. doi: 10.1016/j.surg.2013.05.042. PMID: 24238046.
Copy Download .nbib Format: NLM
Genetic analyses of bone morphogenetic protein 2, 4 and 7 in congenital combined pituitary hormone deficiency.

BMC endocrine disorders

Breitfeld J, Martens S, Klammt J, Schlicke M, Pfäffle R, Krause K, Weidle K, Schleinitz D, Stumvoll M, Führer D, Kovacs P, Tönjes A.
PMID: 24289245
BMC Endocr Disord. 2013 Dec 01;13:56. doi: 10.1186/1472-6823-13-56.

BACKGROUND: The complex process of development of the pituitary gland is regulated by a number of signalling molecules and transcription factors. Mutations in these factors have been identified in rare cases of congenital hypopituitarism but for most subjects with...

Cite
Breitfeld J, Martens S, Klammt J, et al. Genetic analyses of bone morphogenetic protein 2, 4 and 7 in congenital combined pituitary hormone deficiency. BMC Endocr Disord. 2013;13:56doi: 10.1186/1472-6823-13-56.
Breitfeld, J., Martens, S., Klammt, J., Schlicke, M., Pfäffle, R., Krause, K., Weidle, K., Schleinitz, D., Stumvoll, M., Führer, D., Kovacs, P., & Tönjes, A. (2013). Genetic analyses of bone morphogenetic protein 2, 4 and 7 in congenital combined pituitary hormone deficiency. BMC endocrine disorders, 1356. https://doi.org/10.1186/1472-6823-13-56
Breitfeld, Jana, et al. "Genetic analyses of bone morphogenetic protein 2, 4 and 7 in congenital combined pituitary hormone deficiency." BMC endocrine disorders vol. 13 (2013): 56. doi: https://doi.org/10.1186/1472-6823-13-56
Breitfeld J, Martens S, Klammt J, Schlicke M, Pfäffle R, Krause K, Weidle K, Schleinitz D, Stumvoll M, Führer D, Kovacs P, Tönjes A. Genetic analyses of bone morphogenetic protein 2, 4 and 7 in congenital combined pituitary hormone deficiency. BMC Endocr Disord. 2013 Dec 01;13:56. doi: 10.1186/1472-6823-13-56. PMID: 24289245; PMCID: PMC4175098.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 29018 entries